Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2020 TO 2029]"
journalStr:"Arthritis & rheumatology (Hoboken, N.J.)"
topic_facet:"Antibodies, Monoclonal, Humanized"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%22Arthritis%22&type=AllFields
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%22Arthritis%22&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2020+TO+2029%5D%22&filter%5B%5D=journalStr%3A%22Arthritis+%26+rheumatology+%28Hoboken%2C+N.J.%29%22&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22&lookfor=%22Arthritis%22&type=AllFields
PubPharm (45)
1
Towards the Lowest Efficacious Dose : Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2024
von
Kedra, J.
|
Dieudé, P.
|
Giboin, C.
| +133
Wird geladen...
2
Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome : Results From a Phase III Trial
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2024
von
Gattorno, M.
|
Obici, L.
|
Penadés, I.
| +6
Wird geladen...
3
Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis : A Post Hoc Analysis of the NOBILITY Trial
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2024
von
Rovin, B.
|
Furie, R.
|
Ross Terres, J.
| +6
Wird geladen...
4
Risk of serious infection between belimumab and oral immunosuppressants for non-renal systemic lupus erythematosus : comment on the article by Materne et al
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Lee, Y.
|
Chen, C.
|
Chen, S.
CommentOn: Arthritis Rheumatol. 2023 Nov;75(11):1994-2002. - PMID 37262382
Wird geladen...
5
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis : A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Jayne, D.
|
Steffgen, J.
|
Romero-Diaz, J.
| +16
Wird geladen...
6
Comparative efficacy of secukinumab versus tumor necrosis factor inhibitors for Takayasu arteritis : comment on the article by Tian et al
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Singh, K.
|
Misra, D.
CommentOn: Arthritis Rheumatol. 2023 Aug;75(8):1415-1423. - PMID 36916777
Wird geladen...
7
Efficacy and Safety of ABBV-3373, a Novel Anti-Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody-Drug Conjugate, in Adults with Moderate-to-Severe Rheumatoid Arthritis Despite Methotrexate Therapy : A Randomized, Double-Blind, Active-Controlled Proof-of-Concept Phase IIa Trial
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Buttgereit, F.
|
Aelion, J.
|
Rojkovich, B.
| +9
Wird geladen...
8
Tocilizumab in Giant Cell Arteritis : Better Understanding the Benefits
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Buttgereit, F.
|
Palmowski, A.
|
Esen, I.
| +1
Wird geladen...
9
A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Kalunian, K.
|
Furie, R.
|
Morand, E.
| +12
CommentIn: Nat Rev Rheumatol. 2023 Feb;19(2):64. - PMID 36596927
Wird geladen...
10
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus : A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
enthalten in:
Arthritis & rheumatology (Hoboken, N.J.)
| 2023
von
Morand, E.
|
Pike, M.
|
Merrill, J.
| +10
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2020-2029
Filter aufheben
Zeitschrift: Arthritis & rheumatology (Hoboken, N.J.)
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Medienart
45
Aufsätze
45
E-Artikel
45
E-Ressourcen
Zeitschriftentitel
Arthritis & rheumatology (Hoboken, N.J.)
Thema
Antibodies, Monoclonal, Humanized
41
Journal Article
32
Research Support, Non-U.S. Gov't
21
Randomized Controlled Trial
18
Antirheumatic Agents
12
Clinical Trial, Phase III
11
I031V2H011
11
tocilizumab
9
Glucocorticoids
8
Immunosuppressive Agents
7
37CQ2C7X93
7
Clinical Trial, Phase II
7
Multicenter Study
7
canakinumab
6
Research Support, N.I.H., Extramural
5
38RL9AE51Q
5
4F4X42SYQ6
5
73B0K5S26A
5
Immunologic Factors
5
Methotrexate
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2020-
3
2024
7
2023
5
2022
20
2021
10
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
45
Englisch
Haven't found what you're looking for?
Wird geladen...